MSD Global Health Innovation Fund, a corporate venture capital arm of Merck & Co., Inc., Rahway, NJ, USA, who became an Evaxion shareholder in December 2023, is also participating in this offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback